ISRCTN58226681
Completed
未知
Evaluation of the efficacy of oxybutynin and imipramine in the management of detrusor instability
Medical Research Council (MRC) (UK)0 sites345 target enrollmentOctober 25, 2000
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Incontinence
- Sponsor
- Medical Research Council (MRC) (UK)
- Enrollment
- 345
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Failed conservative therapies for urinary dysfunction (nursing interventions)
- •2\. Urodynamicaly proven detrusor instability
Exclusion Criteria
- •1\. Pregnancy
- •2\. Malignancy
- •3\. Fistula
- •4\. Contra\-indications to the use of oxybutynin or imipramine
- •5\. Bladder outflow obstruction (measured urodynamically)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A randomised trial comparing the effectiveness of oxybutynin and mirabegron in reducing symptoms of frequency and urgency in patients with benign prostatic hyperplasia receiving medical treatment with tamsulosin.Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsCTRI/2019/10/021513JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH96
Completed
Phase 4
Comparison of the Effectiveness of 10% Oxybutynin Topical Gel and 20% Aluminum Chloride in Patients with Primary Hyperhidrosis: a Randomized Double-Blind Controlled TrialIRCT20221110056463N2Kerman University of Medical Sciences30
Completed
Phase 3
Assessing the effectiveness of oxybutynin and phenazopyridine and celecoxib in reducing complications in the treatment of bladder tumors.Malignant neoplasm of bladder.Malignant neoplasm of bladderIRCT20171225038070N1Iran University of Medical Sciences120
Completed
Not Applicable
Compare of drug therapy with cognitive behavioral therapy in improvement of enuresis in childrePrimary enuresis.Nonorganic enuresisIRCT201502091061N22Rafsanjan University of Medical Siences45
Not yet recruiting
Phase 3
To study the role of Oxybutinin in infants affected with posterior urethral valveHealth Condition 1: Q642- Congenital posterior urethral valvesCTRI/2023/08/056095Josy Thomas